Ravenel Boykin Curry IV
Eagle Capital Management
Eagle Capital Management Teva Pharma Industries Ltd ADR stake
total: 177
Eagle Capital Management TEVA trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2013 Q2 or earlier
- Held for:
- 2+ quarters
- Latest activity:
- 2013 Q4
According to 2026 Q2 report, Eagle Capital Management doesn't hold any Teva Pharma Industries Ltd ADR (TEVA) shares. Eagle Capital Management has held TEVA since at least 2013 Q2 with 22,400 shares in our earliest available record. Since at least 2013 Q2, Eagle Capital Management has made 1 more transaction.
When did Eagle Capital Management sell Teva Pharma Industries Ltd ADR (TEVA)?
Eagle Capital Management sold off the entire Teva Pharma Industries Ltd ADR (TEVA) position in 2013 Q4.
Estimated cost basis*
- Weighted AVG buy price:
- $39.20
- Weighted AVG sell price:
- $37.77
Eagle Capital Management's historical trades in Teva Pharma Industries Ltd ADR
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.